These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27923758)

  • 41. Analysis of daily teriparatide treatment for osteoporosis in men.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
    Osteoporos Int; 2015 Apr; 26(4):1303-9. PubMed ID: 25567777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis.
    Tu CW; Huang KF; Hsu HT; Li HY; Yang SS; Chen YC
    J Surg Res; 2014 Nov; 192(1):112-6. PubMed ID: 24948545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Ha KY; Park KS; Kim SI; Kim YH
    Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?
    Anagnostis P; Karras SN; Goulis DG
    Curr Med Res Opin; 2014 Jun; 30(6):1177-8. PubMed ID: 24579907
    [No Abstract]   [Full Text] [Related]  

  • 46. [Once-weekly teriparatide treatment on osteoporosis].
    Nakano T
    Clin Calcium; 2014 Jan; 24(1):100-5. PubMed ID: 24369286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model.
    Lehman RA; Dmitriev AE; Cardoso MJ; Helgeson MD; Christensen CL; Raymond JW; Eckel TT; Riew KD
    Spine (Phila Pa 1976); 2010 Jan; 35(2):146-52. PubMed ID: 20081509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical optimization of osteoporosis for adult spinal deformity surgery: a state-of-the-art evidence-based review of current pharmacotherapy.
    Zhang AS; Khatri S; Balmaceno-Criss M; Alsoof D; Daniels AH
    Spine Deform; 2023 May; 11(3):579-596. PubMed ID: 36454531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].
    Sowa H; Hamaya E; Yamamoto T
    Clin Calcium; 2011 Jan; 21(1):9-16. PubMed ID: 21187589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of osteoanabolics in fracture nonunion].
    Peters KM; Tuncel T
    Orthopade; 2015 Sep; 44(9):710-715. PubMed ID: 26205360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic administration of pharmacological agents and bone repair: what can we expect.
    Bukata SV
    Injury; 2011 Jun; 42(6):605-8. PubMed ID: 21507402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of repeated and multiple new-onset osteoporotic vertebral compression fractures with teriparatide.
    Tu PH; Liu ZH; Lee ST; Chen JF
    J Clin Neurosci; 2012 Apr; 19(4):532-5. PubMed ID: 22341147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
    Bonafede MM; Shi N; Bower AG; Barron RL; Grauer A; Chandler DB
    Osteoporos Int; 2015 Mar; 26(3):1203-12. PubMed ID: 25567774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.
    Finkelstein JS; Leder BZ; Burnett SM; Wyland JJ; Lee H; de la Paz AV; Gibson K; Neer RM
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2882-7. PubMed ID: 16684825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teriparatide fracture effectiveness in the real world.
    Krege JH; Burge RT; Marin F
    Osteoporos Int; 2015 Aug; 26(8):2217-8. PubMed ID: 25906242
    [No Abstract]   [Full Text] [Related]  

  • 59. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.
    Goldhahn J; Féron JM; Kanis J; Papapoulos S; Reginster JY; Rizzoli R; Dere W; Mitlak B; Tsouderos Y; Boonen S
    Calcif Tissue Int; 2012 May; 90(5):343-53. PubMed ID: 22451221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
    Chen P; Miller PD; Delmas PD; Misurski DA; Krege JH
    J Bone Miner Res; 2006 Nov; 21(11):1785-90. PubMed ID: 17002571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.